{"denoms":[{"counts":[{"groupId":"BG000","value":"614"},{"groupId":"BG001","value":"612"},{"groupId":"BG002","value":"1226"}],"units":"Participants"}],"groups":[{"description":"Participants with Metastatic Colorectal Cancer administered Placebo and FOLFIRI (Irinotecan, 5- Fluorouracil, and Leucovorin)","id":"BG000","title":"Placebo/Folfiri"},{"description":"Participants with Metastatic Colorectal Cancer administered 4 mg/kg of Aflibercept and FOLFIRI (Irinotecan, 5- Fluorouracil, and Leucovorin)","id":"BG001","title":"Aflibercept/Folfiri"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.8","value":"60.2"},{"groupId":"BG001","spread":"10.5","value":"59.5"},{"groupId":"BG002","spread":"10.7","value":"59.8"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"376"},{"groupId":"BG001","value":"407"},{"groupId":"BG002","value":"783"}]}],"title":"<65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"199"},{"groupId":"BG001","value":"172"},{"groupId":"BG002","value":"371"}]}],"title":">=65 but <75 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"72"}]}],"title":">=75 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"353"},{"groupId":"BG001","value":"365"},{"groupId":"BG002","value":"718"}]}],"title":"Male"},{"categories":[{"measurements":[{"groupId":"BG000","value":"261"},{"groupId":"BG001","value":"247"},{"groupId":"BG002","value":"508"}]}],"title":"Female"}],"paramType":"NUMBER","title":"Sex/Gender, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"523"},{"groupId":"BG001","value":"548"},{"groupId":"BG002","value":"1071"}]}],"title":"Caucasian/White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"43"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"51"},{"groupId":"BG001","value":"35"},{"groupId":"BG002","value":"86"}]}],"title":"Asian/Oriental"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"26"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"}]}],"title":"ARGENTINA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"96"}]}],"title":"AUSTRALIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"}]}],"title":"AUSTRIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"82"}]}],"title":"BELGIUM"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"48"}]}],"title":"BRAZIL"},{"categories":[{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"64"}]}],"title":"CHILE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"77"}]}],"title":"CZECH REPUBLIC"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"15"}]}],"title":"DENMARK"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"10"}]}],"title":"ESTONIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"title":"FRANCE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"35"}]}],"title":"GERMANY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"19"}]}],"title":"GREECE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"49"}]}],"title":"ITALY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"65"}]}],"title":"KOREA, REPUBLIC OF"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"34"}]}],"title":"NETHERLANDS"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"20"}]}],"title":"NEW ZEALAND"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"33"}]}],"title":"NORWAY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"56"}]}],"title":"POLAND"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"}]}],"title":"PUERTO RICO"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"32"}]}],"title":"ROMANIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"40"},{"groupId":"BG002","value":"75"}]}],"title":"RUSSIAN FEDERATION"},{"categories":[{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"67"}]}],"title":"SOUTH AFRICA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"55"}]}],"title":"SPAIN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"14"}]}],"title":"SWEDEN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"}]}],"title":"TURKEY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"22"}]}],"title":"UKRAINE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"47"},{"groupId":"BG001","value":"52"},{"groupId":"BG002","value":"99"}]}],"title":"UNITED KINGDOM"},{"categories":[{"measurements":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"61"},{"groupId":"BG002","value":"132"}]}],"title":"UNITED STATES"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"350"},{"groupId":"BG001","value":"349"},{"groupId":"BG002","value":"699"}]}],"title":"Participants with ECOG Score = 0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"250"},{"groupId":"BG001","value":"250"},{"groupId":"BG002","value":"500"}]}],"title":"Participants with ECOG Score = 1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"27"}]}],"title":"Participants with ECOG Score = 2"}],"description":"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. \"0\" reflects a fully active participant, able to carry on all pre-disease performance without restriction. \"1\" reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. \"2\" reflects an ambulatory participant, who is up and about more than 50% of waking hours, and capable of all self-care but unable to carry out any work activities.","paramType":"NUMBER","title":"Eastern Cooperative Oncology Group (ECOG) performance status score","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"187"},{"groupId":"BG001","value":"186"},{"groupId":"BG002","value":"373"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"427"},{"groupId":"BG001","value":"426"},{"groupId":"BG002","value":"853"}]}],"title":"No"}],"description":"Number of participants randomized in the prior bevacizumab stratum as per the interactive voice response system (IVRS).","paramType":"NUMBER","title":"Prior Bevacizumab","unitOfMeasure":"participants"}]}